Yale Pathology Tissue Services (YPTS) Shared Resource, sited in the Departs of Pathology is a longstanding shared resource providing broad tissue services to the Cancer Center and beyond. The Mission of YPTS is to provide the maximum amount and quality of human tissue for research at Yale University without impacting diagnostic quality, accuracy and safety in anatomic pathology. The service is structured into a modular architecture that integrates tissue procurement &distribution (TPD), developmental histology (DH), and clinical trials tissue services (GTTS). The TPD Module has nearly 50 standard operating procedures (SOPs) for collection of specific fresh tissue resources. About V4 of these protocols serve 12 YCC members representing about 30% of usage. The DH Module provides a range of histology services from standard tissue processing to quantitative analysis, whole slide imaging tissue microarray construction and analysis and laser capture microdissection. This facility has supported 71 YGC member users from all research programs, which represents about 29% of overall use. The GTTS module is a new addition to the resource since starting in 2010. Its function is to serve requests for tissue from cooperative group or other clinical trials that request a block or a portion of a block from the original diagnostic sample. The division reviews the original material and then ships cores of tissue blocks or recut slides to the requesting institutions. Their services are used by 6 YCC members representing about 26% of their usage. The facility is operated lead by Dr. David Rimm, assisted by Dr. Alex Vortmeyer. Each division has a technical director and there are 12 other physicians or technicians on the staff. Future plans include a move to a new larger laboratory and addition of new services included services in a CLIA certified lab and quantitative immunofluorescence services.

Public Health Relevance

Biospecimen access is a critical component of cancer research. The mission of this core is to maximize the access to biospecimens for all Yale Cancer Center users. The core both collects and processes tissue to optimize data that can be obtained from each specimen. Biospecimen collection and analysis contributes directly to the translational goals of users from nearly every program and project associated with cancer.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Yale University
New Haven
United States
Zip Code
Ols, Michelle L; Cullen, Jaime L; Turqueti-Neves, Adriana et al. (2016) Dendritic Cells Regulate Extrafollicular Autoreactive B Cells via T Cells Expressing Fas and Fas Ligand. Immunity 45:1052-1065
Gale, Molly; Sayegh, Joyce; Cao, Jian et al. (2016) Screen-identified selective inhibitor of lysine demethylase 5A blocks cancer cell growth and drug resistance. Oncotarget 7:39931-39944
Ducker, Gregory S; Chen, Li; Morscher, Raphael J et al. (2016) Reversal of Cytosolic One-Carbon Flux Compensates for Loss of the Mitochondrial Folate Pathway. Cell Metab 23:1140-53
Adams, Brian D; Wali, Vikram B; Cheng, Christopher J et al. (2016) miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer. Cancer Res 76:927-39
Santin, Alessandro D; Bellone, Stefania; Buza, Natalia et al. (2016) Regression of Chemotherapy-Resistant Polymerase ε (POLE) Ultra-Mutated and MSH6 Hyper-Mutated Endometrial Tumors with Nivolumab. Clin Cancer Res 22:5682-5687
de Haydu, Christopher; Black, Jonathan D; Schwab, Carlton L et al. (2016) An update on the current pharmacotherapy for endometrial cancer. Expert Opin Pharmacother 17:489-99
Hollander, Lindsay; Guo, Xiaojia; Velazquez, Heino et al. (2016) Renalase Expression by Melanoma and Tumor-Associated Macrophages Promotes Tumor Growth through a STAT3-Mediated Mechanism. Cancer Res 76:3884-94
Zhao, Siming; Bellone, Stefania; Lopez, Salvatore et al. (2016) Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition. Proc Natl Acad Sci U S A 113:12238-12243
Park, Sin-Aye; Lee, Jong Woo; Herbst, Roy S et al. (2016) GSK-3α Is a Novel Target of CREB and CREB-GSK-3α Signaling Participates in Cell Viability in Lung Cancer. PLoS One 11:e0153075
Stein, Stacey M; James, Edward S; Deng, Yanhong et al. (2016) Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer. Br J Cancer 114:737-43

Showing the most recent 10 out of 275 publications